Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aehr Test Systems (AEHR) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance

Aehr Test Systems
YieldMax Magnificent 7 Fund of Option Income ETFs

Price performance

Price movement over the last 24 hours

Key statistics

Aehr Test Systems vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Aehr Test Systems trades at $66.03 (market cap $2.11B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.53. The key difference: Aehr Test Systems is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.

AEHRYMAG
Market Cap
$2.11B
Sector
TechnologyIncome / Options Overlay
52-Week High
$116.58$15.98
52-Week Low
$13.29$11.00
Enterprise Value
$2.08B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aehr Test Systems

AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.

Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.

YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG trades at $11.70, up 2.01% today, but technical indicators signal bearish momentum with resistance at $12. The ETF maintains weekly dividend distributions, though recent analysis highlights concerns about NAV decay from its synthetic covered call strategy on Magnificent Seven stocks. Mixed sentiment prevails with some analysts seeing tactical opportunities in rangebound markets while others cite limited upside potential.

Outlook remains cautious due to structural NAV erosion risks and high expense ratios. The fund's performance depends heavily on volatility monetization from its underlying option strategy, creating both income opportunities and capital depreciation risks in trending markets. Investors should weigh the high yield against potential long-term underperformance versus the broader market.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aehr Test Systems

Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.

Read more on AEHR

About YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.

Read more on YMAG